Deltex Medical Group plc DX9.F Stock
Deltex Medical Group plc Price Chart
Deltex Medical Group plc DX9.F Financial and Trading Overview
Deltex Medical Group plc stock price | 0.0005 EUR |
Previous Close | 0.0055 EUR |
Open | 0.005 EUR |
Bid | 0.0055 EUR x N/A |
Ask | 0.02 EUR x N/A |
Day's Range | 0.005 - 0.005 EUR |
52 Week Range | 0.003 - 0.02 EUR |
Volume | 15K EUR |
Avg. Volume | 935 EUR |
Market Cap | 9.04M EUR |
Beta (5Y Monthly) | 0.778544 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
DX9.F Valuation Measures
Enterprise Value | 5.49M EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 3.6414585 |
Price/Book (mrq) | 1.6666666 |
Enterprise Value/Revenue | 2.21 |
Enterprise Value/EBITDA | -6.042 |
Trading Information
Deltex Medical Group plc Stock Price History
Beta (5Y Monthly) | 0.778544 |
52-Week Change | -60.71% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.02 EUR |
52 Week Low | 0.003 EUR |
50-Day Moving Average | 0.00737 EUR |
200-Day Moving Average | 0.006475 EUR |
DX9.F Share Statistics
Avg. Volume (3 month) | 935 EUR |
Avg. Daily Volume (10-Days) | 5.24K EUR |
Shares Outstanding | 709.06M |
Float | 419.8M |
Short Ratio | N/A |
% Held by Insiders | 75.21% |
% Held by Institutions | 22.82% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -46.13% |
Operating Margin (ttm) | -38.15% |
Gross Margin | 74.09% |
EBITDA Margin | -36.58% |
Management Effectiveness
Return on Assets (ttm) | -10.22% |
Return on Equity (ttm) | -55.44% |
Income Statement
Revenue (ttm) | 2.48M EUR |
Revenue Per Share (ttm) | 0.004 EUR |
Quarterly Revenue Growth (yoy) | 11.50% |
Gross Profit (ttm) | 1.84M EUR |
EBITDA | -908000 EUR |
Net Income Avi to Common (ttm) | -1145000 EUR |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 471K EUR |
Total Cash Per Share (mrq) | 0.001 EUR |
Total Debt (mrq) | 2.23M EUR |
Total Debt/Equity (mrq) | 100.22 EUR |
Current Ratio (mrq) | 0.748 |
Book Value Per Share (mrq) | 0.003 |
Cash Flow Statement
Operating Cash Flow (ttm) | -606000 EUR |
Levered Free Cash Flow (ttm) | -1065250 EUR |
Profile of Deltex Medical Group plc
Country | Germany |
State | N/A |
City | Chichester |
Address | Terminus Road |
ZIP | PO19 8TX |
Phone | 44 12 4377 4837 |
Website | https://www.deltexmedical.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 44 |
Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, Spain, Canada, and internationally. It offers oesophageal Doppler Probes that is used to measure a patient's central vascular blood flow and fluid status to measure real time blood velocities within the descending aorta; TrueVue Loops that plots aortic blood flow velocity and aortic blood pressure monitoring throughout every heartbeat; High Definition Impedance Cardiography, a non-invasive cardiac function and fluid status monitoring system for awake patients; and PressureWave, a pulse pressure waveform analysis algorithm used during periods of instability or for periods when the ODM mode is unavailable. The company also provides Deltex Medical Esophageal Doppler Simulator that enables clinicians to practice probe insertion, focusing, and waveform interpretation outside of a patient setting. Its products are used in Covid-19 critical care; sepsis; major abdominal, laparoscopic, and spinal surgeries; cardiac, trauma, and transplant procedures; and post-operative acute kidney injury monitoring. Deltex Medical Group plc was incorporated in 2000 and is headquartered in Chichester, the United Kingdom.
Q&A For Deltex Medical Group plc Stock
What is a current DX9.F stock price?
Deltex Medical Group plc DX9.F stock price today per share is 0.0005 EUR.
How to purchase Deltex Medical Group plc stock?
You can buy DX9.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Deltex Medical Group plc?
The stock symbol or ticker of Deltex Medical Group plc is DX9.F.
Which industry does the Deltex Medical Group plc company belong to?
The Deltex Medical Group plc industry is Medical Devices.
How many shares does Deltex Medical Group plc have in circulation?
The max supply of Deltex Medical Group plc shares is 7.48B.
What is Deltex Medical Group plc Price to Earnings Ratio (PE Ratio)?
Deltex Medical Group plc PE Ratio is now.
What was Deltex Medical Group plc earnings per share over the trailing 12 months (TTM)?
Deltex Medical Group plc EPS is 0 EUR over the trailing 12 months.
Which sector does the Deltex Medical Group plc company belong to?
The Deltex Medical Group plc sector is Healthcare.